Chardan Capital initiated coverage of Corvex (NASDAQCM:MOVE) with a Buy recommendation on September 16, 2026. Prior to this action, the stock closed at $10.71, marking a significant decline of -28.07% over the past week from a baseline of $14.89 on September 8, and a -8.62% decrease from $11.72 on August 14.
The consensus target price for Corvex remains at $30.60, implying a potential upside of 185.71% from the current price. As of April 1, 2026, aggregate analyst recommendations included 2 strong buy, 4 buy, and 1 hold, giving a positive recommendation rate of 85.7%. In a recent earnings report on May 19, 2026, Corvex posted an actual EPS of -3.13 compared to an estimate of -3.672, with actual revenue reported at $510,000 against an estimate of $7.78 million.
On September 2, 2026, Corvex disclosed in a Form 8-K that it entered a Purchase Agreement for 3,904,970 common shares at $7.75 each and 353.098 Series D Non-Voting Convertible Preferred Shares at a price of $7,750.00 each.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
